Increased IL-21 Expression Induces Granzyme B in Peripheral CD5⁺ B Cells as a Potential Counter-Regulatory Effect in Primary Sjögren’s Syndrome

Table 1

The demographic characteristics of subjects enrolled in the study.

	Healthy individuals	pSS patients	Patients with EGMs	Patients without EGMs
Number	24	32	18	14
Age (years), mean ± SD	53.69 ± 9.12	58.98 ± 7.67	60.48 ± 6.47	57.04 ± 9.12
Sex (man/woman)	2/22	2/30	1/17	1/13

EGMs: extraglandular manifestations; pSS: primary Sjögren’s syndrome.